Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Inhaled Cyclosporine for Bronchiolitis Obliterans
NCT01273207Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 2012
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cyclosporine Inhalation Solution in Bronchiolitis Obliterans (BO), sponsored by National Heart, Lung, and Blood Institute. Started Mar 2012; status: completed.
02
Drugs
Cyclosporine Inhalation Solution
03
Conditions
Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on NCT01273207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273207.